Effects of 2 mg and 4 mg atropine sulfate on the performance of U.S. Army helicopter pilots.
Atropine autoinjectors are issued to aviators for use in the event of organophosphate poisoning on the battlefield. This investigation assessed the effects of unchallenged 2 mg and 4 mg doses on flight performance, vision, tracking, cognitive performance, and electroencephalograms of 12 Army aviators. Effects were seen most often with the 4 mg dose in terms of aircraft control problems, vision disturbances, impaired tracking, reduced cortical activation, and decreased cognitive skill. These problems indicate helicopter tactical flight is dangerous after an unchallenged 4 mg dose. Other types of flight should also be avoided for at least 12 h after atropine.
Caldwell
J A
JA
Biomedical Applications Research Division, U.S. Army Aeromedical Research Laboratory, Fort Rucker, AL 36362.
Stephens
R L
RL
Carter
D J
DJ
Jones
H D
HD
D000328:Adult; D000337:Aerospace Medicine; D000401:Aircraft; D001285:Atropine / Q000008:administration & dosage / Q000494:pharmacology*; D003071:Cognition / Q000187:drug effects*; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D008297:Male; D008570:Memory, Short-Term / Q000187:drug effects; D008606:Mental Processes / Q000187:drug effects*; D008889:Military Personnel; D011597:Psychomotor Performance / Q000187:drug effects*; D014785:Vision, Ocular / Q000187:drug effects
D001285:Atropine